Partners | Companies


IMIDomics is a biotechnological company identifying more specific and more efficacious drugs for patients suffering from immune-mediated inflammatory diseases (IMIDs).  We are leveraging multiple technological approaches and large collections of well-defined patients. The company's mission is to accelerate new target identification and validation for a diverse group of IMIDs including the musculoskeletal, skin and gastrointestinal therapeutic areas. Our R&D team is located in Barcelona.